Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2

Human Molecular Genetics

Volumn 9, Issue 5, 2000, Pages 803-811

  Azzouz, Mimoun ^b   Hottinger, Andreas ^b   Paterna, Jean Charles ^a   Zurn, Anne D ^b   Aebischer, Patrick ^b   Büeler, Hansruedi ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b University of Lausanne Medical Center   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GREEN FLUORESCENT PROTEIN; PROTEIN BCL 2;

ADENO ASSOCIATED VIRUS; AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; FAMILIAL DISEASE; GENE TRANSFER; LUMBAR SPINE; MOTONEURON; MOUSE; NEUROMUSCULAR FUNCTION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; TRANSGENIC MOUSE;

ADENO-ASSOCIATED VIRUS; ANIMALIA; MUS MUSCULUS;

EID: 0034701321     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.5.803     Document Type: Article

References (54)

1. Williams, D.B. and Windebank, A.J. (1991) Motor neuron disease (amyotrophic lateral sclerosis). Mayo Clin. Proc., 66, 54-82.
2. Rosen, D., Siddique, T., Patterson, D., Figlewicz, D., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J., Deng, H. et al. (1993) Mutation in Cu/ Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59-62.
3. Gurney, M., Pu, H., Chiu, A., Dal Canto, M., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W., Deng, H.-X. et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 264, 1772-1775.
4. Wong, P., Pardo, C., Borchelt, D., Lee, M., Copeland, N., Jenkins, N., Sisodia, S., Cleveland, D. and Price, D. (1995) An adverse property of a familial ALS-linked SODI mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron, 14, 1105-1116.
5. Ripps, E., Huntley, G.W., Hof, P.R., Morrison, J.H. and Gordon J.W. (1995) Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA, 92, 689-693.
6. Brown Jr, R.H. (1995) Superoxide dismutase in familial amyotrophic sclerosis: models for gain of function. Curr. Opin. Neurobiol., 5, 841-846.
7. Wong, P.C., Rothstein, J.D. and Price, D.L. (1998) The genetic and molecular mechanisms of motor neuron disease. Curr. Opin. Neurobiol., 8, 791-799.
8. Trotti, D., Rolfs, A., Danbolt, N., Brown, R.H. and Hediger, M.A. (1999) SODI mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nature Neurosci., 2, 427-433.
9. Rabizadeh, S., Gralla, E., Borchelt, D., Gwinn, R., Valentine, J., Sisodia, S., Wong, P., Lee, M., Hann, H. and Bredesen, D. (1995) Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc. Natl Acad. Sci. USA, 92, 3024-3028.
10. Ghadge, G.D., Lee, J.P., Bindokas, V.P., Jordan, J., Ma L., Miller, R.J. and Roos, R.P. (1997) Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J. Neurosci., 17, 8756-8766.
11. Pasinelli, P., Borchelt, D.R., Houseweart, M.K., Cleveland, D.W. and Brown, R.H. (1998) Caspase-1 is activated in neuronal cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. Proc. Natl Acad. Sci. USA, 95, 15763-15768.
12. Kostic, V., Jackson-Lewis, V., de Bilbao, F., Dubois-Dauphin, M. and Przedborski, S. (1997) Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science, 277, 559-562.
13. Friedlander, R.M., Brown, R.H., Gagliardini, V., Wang, J. and Yuan, J. (1997) Inhibition of ICE slows ALS in mice. Nature, 388, 31.
14. Rabinowitz, J.E. and Samulski, J. (1998) Adeno-associated virus expression systems for gene transfer. Curr. Opin. Biotechnol., 9, 470-475.
15. Büler, H. (1999) Adeno-associated viral vectors for gene transfer and gene therapy. Biol. Chem., 380, 613-622.
16. Jooss, K., Yang, Y., Fisher, K.J. and Wilson, J.M. (1998) Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Virol. 72., 4212-4213.
17. Mandel, R.J., Spratt, S.K., Snyder, R.O. and Leff, S.E. (1997) Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rat. Proc. Natl Acad. Sci. USA, 94, 14083-14088.
18. During, M.J., Samulski, R.J., Elsworth, J.D., Kaplitt, M.G., Leone, P., Xiao, X., Li, J., Freese, A., Taylor, J.R., Roth, R.H. et al. (1998) In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Ther., 5, 820-827.
19. Azzouz, M., Leclerc, N., Gurney, M., Warter, J.M., Poindron, P. and Borg, J. (1997) Progressive motor neuron impairment in an animal model of ALS. Muscle Nerve, 20, 45-51.
20. Haase, G., Kennel, P., Pettmann, B., Vigne, E., Akli, S., Revah, F., Schmalbruch, H. and Kahn, A. (1997) Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nature Med., 3, 429-436.
21. Peel, A.L., Zolotukhin, S., Schrimsher, G.W., Muzyczka, N. and Reier, P.J. (1997) Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene Ther., 4, 16-24.
22. Kaplitt, M.G., Leone, P., Samulski, R.J., Xiao, X., Praff, D.W., O'Malley, K.L. and During, M.J. (1994) Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet., 8, 148-154.
23. Mu, X., He, J., Anderson, D.W., Trojanowski, J.Q. and Springer, J.E. (1996) Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann. Neurol., 40, 379-386.
24. Chiu, A.Y., Zhai, P., Dal Canto, M.C., Peters, T.M., Kwon, Y.W., Prattis, S.M. and Gurney, M.E. (1995) Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci., 6, 349-362.
25. Migheli, A., Atzori, C., Piva, R., Tortarolo, M., Girelli, M., Schiffer, D. and Bendotti, C. (1999) Lack of apoptosis in mice with ALS [letter]. Nature Med., 5, 966-967.
26. Vander Heiden, M.G. and Thompson, C.B. (1999) Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nature Cell Biol., 1, E209-E216.
27. 2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett., 14, 365-368.
28. Hockenbery, D.M., Oltvai, Z.N., Yin, X.M., Milliman, C.L. and Korsmeyer, S.J. (1993). B,cl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75, 241-251.
29. Kane, D.J., Sarafian, T.A., Anton, R., Hahn, H., Gralla, E.B., Valentine, J.S., Ord, T. and Bredesen, D.E. (1993). Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science, 262, 1274-1277.
30. Hochman, A., Sternin, H., Gorodin, S., Korsmeyer, S., Ziv, I., Melamed, E. and Offen, D. (1998) Enhanced oxidative stress and altered antioxidants in brains of Bcl-2-deficient mice. J. Neurochem., 71, 741-748.
31. Bogdanov, M.B., Ferrante, R.J., Mueller, G., Ramos, L.E., Martinou, J.C. and Beal, M.F. (1999) Oxidative stress is attenuated in mice overexpressing BCL-2. Neurosci. Lett., 262, 33-36.
32. Ferrante, R.J., Shinobu, L.A., Schulz, J.B., Matthews, R.T., Thomas, C.E., Kowall, N.W., Gurney, M.E. and Beal, M.F. (1997). Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Ann. Neurol., 42, 326-334.
33. Andrus, P.K., Fleck, T.J., Gurney, M.E. and Hall, E.D. (1998) Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem., 71, 2041-2048.
34. Tritschler, H.J., Packer, L. and Medori, R. (1994) Oxidative stress and mitochondrial dysfunction in neurodegeneration. Biochem. Mol. Biol. Int., 34, 169-181.
35. Schapira, A.H. (1998) Mitochondrial dysfunction in neurodegenerative disorders. Biochem. Biophys. Acta, 1366, 225-233.
36. Satoh, T., Enokido, Y., Aoshima, H., Uchiyama, Y. and Hatanaka, H. (1997) Changes in mitochondrial membrane potential during oxidative stress-induced apoptosis in PC12 cells. J. Neurosci. Res., 50, 413-420.
37. Bruce-Keller, A.J., Begley, J.G., Fu, W., Butterfield, D.A., Bredesen, D.E., Hutchins, J.B., Hensley, K. and Mattson, M.P. (1998) Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta- peptide. J. Neurochem., 70, 31-39.
38. Mourelatos, Z., Gonatas, N.K., Stieber, A., Gurney, M.E. and Dal Canto, M.C. (1996) The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc. Natl Acad. Sci. USA, 93, 5472-5477.
39. Kong, J. and Xu, Z. (1998) Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SODI. J. Neurosci., 18, 3241-3250.
40. 2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science, 284, 339-343.
41. Murphy, A.N., Bredesen, D.E., Cortopassi, G., Wang, E. and Fiskum, G. (1996) Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc. Natl Acad. Sci. USA, 93, 9893-9898.
42. 2+ mobilization. Am. J. Physiol., 275, C832-C839.
43. Chakraborti, T., Das, S., Mondal, M., Roychoudhury, S. and Chakraborti, S. (1999) Oxidant, mitochondria and calcium: an overview. Cell Signal., 11, 77-85.
44. Zhong, L.T., Kane, D.J. and Bredesen, D.E. (1993) Bcl-2 blocks glutamate toxicity in neural cell lines. Brain Res. Mol. Brain Res., 19, 353-355.
45. Gurney, M., Cutting, F.B., Zhai, P., Doble, A., Taylor, C., Andrus, P.K. and Hall, E.D. (1996) Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol., 39, 147-157.
46. Reinholz, M.M., Merkle, C.M. and Poduslo, J.F. (1999) Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis. Exp. Neurol., 159, 204-216.
47. Nagano, S., Ogawa, Y., Yanagihara, T. and Sakoda, S. (1999) Benefit of a combined treatment with trientine and ascorbate in familial amyotrophic lateral sclerosis model mice. Neurosci. Lett., 265, 159-162.
48. Klivenyi, P., Ferrante, R.J., Matthews, R.T., Bogdanov, M.B., Klein, A.M., Andreassen, O.A., Mueller, G., Wermer, M., Kaddurah-Daouk, R. and Beal, F. (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Med., 5, 347-350.
49. Ye, X., Rivera, V.M., Zoltick, P., Cerasoli Jr, F., Schnell, M.A., Gao, G., Hughes, J.V., Gilman, M. and Wilson, J.M. (1999) Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science, 283, 88-91.
50. Mohajeri, M.H., Figlewicz, D.A. and Bonn, M.C. (1999) Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Hum. Gene Ther., 10, 1853-1866.
51. Samulski, R.J., Chang, L.S. and Shenk, T. (1989) Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol., 63, 3822-3828.
52. Snyder, R.O., Xiao, X. and Samulski, R.J. (1997) Production of recombinant adeno-associated viral vectors. In Dracopoli, N.C., Haines, J.L., Korf, B.R., Moir, D.T., Morton, C.C., Seidman, C.E., Seidman, J.G. and Smith D.R. (eds), Current Protocols in Human Genetics. John Wiley & Sons, USA.
53. Cozzari, C., Howard, J. and Hartman, B. (1990) Analysis of epitopes on choline acetyltransferase (ChAT) using monoclonal antibodies (Mabs). Soc. Neurosci. Abstr., 16, 200.
54. Malhotra, S.K., Svensson, M., Aldskogius, H., Bhatnagar, R., Das, G.D. and Shnitka, T.K. (1993) Diversity among reactive astrocytes: proximal reactive astrocytes in lacerated spinal cord preferentially react with monoclonal antibody J1-31. Brain Res. Bull., 30, 395-404.